Clinical Trials Browser

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT01057121 2022-02-08

Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma

Phase 1/2 Completed

38 enrolled 11 charts

Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

NCT01109004 2021-12-09

BMT CTN 0702

Phase 3 Completed

758 enrolled 21 charts

Plasma cell

Hematologic Diseases, Multiple Myeloma, Disease Progression

NCT01208051 2021-07-15

Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer

Phase 1/2 Completed

127 enrolled 18 charts

EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Adenocarcinoma, Follicular

NCT01402284 2021-03-02

Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients

Phase 2 Completed

45 enrolled 15 charts

Plasma cell

Multiple Myeloma

NCT02322320 2020-05-11

Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)

Phase 3 Completed

273 enrolled 16 charts

Plasma cell

Hematologic Diseases, Multiple Myeloma, Disease Progression

NCT01076543 2019-10-16

Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Phase 1/2 Completed

110 enrolled 17 charts

Lymphoid

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Lymphoma, T-Cell, Lymphoma, B-Cell, Marginal Zone

NCT00553644 2018-10-30

Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Phase 2 Completed

53 enrolled 8 charts

Lymphoid

Lymphoma, Mantle-Cell

NCT00942578 2018-10-11

A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer

Phase 2 Completed

63 enrolled 23 charts

Genitourinary

Prostatic Neoplasms

NCT01675141 2018-02-05

Lenalidomide Maintenance Therapy for Multiple Myeloma

Phase 2 Terminated

11 enrolled 7 charts

Plasma cell

Multiple Myeloma

NCT00410605 2017-09-01

Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma

Phase 2 Completed

39 enrolled 10 charts

Plasma cell

Multiple Myeloma

NCT00482911 2017-03-27

Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma

Phase 2 Terminated

12 enrolled 10 charts

Dermatologic

Uveal Melanoma

NCT00109005 2017-01-02

Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma

Phase 2 Completed

17 enrolled 11 charts

Dermatologic

Uveal Melanoma, Melanoma

NCT00522392 2015-06-26

Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone

Phase 3 Terminated

48 enrolled 9 charts

Plasma cell

Multiple Myeloma

NCT00227591 2014-05-21

Lenalidomide and Prednisone in Treating Patients With Myelofibrosis

Phase 2 Completed

48 enrolled 7 charts

Myeloid

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT00439231 2014-01-13

Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Phase 2 Completed

33 enrolled 8 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell